Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMP2-specific TCR-T cells in recurrent/metastatic nasopharyngeal carcinoma
NCT03925896Phase 1Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Primary endpoint: Maximum Tolerated Dose at 2 years. Status: unknown.
02
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03925896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03925896.